BioMachines Signs on European Distributor

BioMachines

, a developer and manufacturer of automation tools for use in the acceleration of drug discovery, has signed on a European distribution partner.

Working with BioMachines will be Disruptive Technologies, which is based in Paris.

"Europe is a very large market and there is a demand for our products", said Tom Larrichio, BioMachines' chief executive officer. "We are very pleased to have found a company like Disruptive Technologies, whose principals have deep knowledge and understanding of the proteomics and genomics market in Europe. They will serve us well."